EAHAD/LinkedIn
Apr 19, 2026, 09:49
Evolving Perspectives on Gene Therapy in Haemophilia – EAHAD
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
“We are pleased to share that the abstract ‘Knowledge and Perspectives on Haemophilia Gene Therapy – Results of the EAHAD Gene Therapy Survey’ has been accepted for poster presentation at the ISTH 2026 Congress.
This recognition highlights the importance of understanding evolving perspectives on gene therapy within the haemophilia community.
We look forward to sharing these insights with the wider scientific audience next July.”
Stay updated with Hemostasis Today.
-
Apr 19, 2026, 09:35Abdul Mannan: Recognition and Management of Febrile Non-Haemolytic Transfusion Reactions in Clinical Practice
-
Apr 19, 2026, 09:20David McIntosh: The Evolving Safety Framework for Plasma-Derived Therapies
-
Apr 19, 2026, 08:48Mike Thompson: Breaking Down the C-TRACT Trial on Endovascular Therapy for Post-Thrombotic Syndrome
-
Apr 19, 2026, 08:33Mohamed Elgayar։ Not Every Elevated Troponin in a Child Is Myocarditis
-
Apr 19, 2026, 07:38Expanding Haemophilia Detection and Access in Sierra Leone – NNHF
-
Apr 19, 2026, 05:35Mohammed Elmourtada Abdulgayoom։ New Perspectives on Anemia of Chronic Disease and Its Treatment
-
Apr 19, 2026, 05:14Mehmet Nevzat Cizmeci: Neuroimaging in Preterm Infants With Intraventricular Hemorrhage Is Evolving
-
Apr 19, 2026, 04:47Test Your Hematology Knowledge with ASH Questions and Answers – ASH
-
Apr 19, 2026, 04:26Priyanka Raheja: Happy World Haemophilia Day from The Royal London Haemophilia Centre